nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—ABCB11—Tamoxifen—pancreatic cancer	0.0582	0.0774	CbGbCtD
Quinidine—ORM1—Erlotinib—pancreatic cancer	0.0386	0.0512	CbGbCtD
Quinidine—CYP1A1—Dacarbazine—pancreatic cancer	0.0321	0.0427	CbGbCtD
Quinidine—ABCC2—Tamoxifen—pancreatic cancer	0.0306	0.0407	CbGbCtD
Quinidine—SLCO1B1—Irinotecan—pancreatic cancer	0.0268	0.0355	CbGbCtD
Quinidine—CYP1A1—Tamoxifen—pancreatic cancer	0.0255	0.0339	CbGbCtD
Quinidine—CYP2E1—Dacarbazine—pancreatic cancer	0.0248	0.033	CbGbCtD
Quinidine—ABCB11—Doxorubicin—pancreatic cancer	0.0244	0.0325	CbGbCtD
Quinidine—ABCC2—Irinotecan—pancreatic cancer	0.0235	0.0312	CbGbCtD
Quinidine—KCNH2—Sunitinib—pancreatic cancer	0.0224	0.0298	CbGbCtD
Quinidine—CYP1A1—Erlotinib—pancreatic cancer	0.0217	0.0289	CbGbCtD
Quinidine—CYP3A7—Tamoxifen—pancreatic cancer	0.0204	0.0272	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0204	0.0272	CbGbCtD
Quinidine—CYP2E1—Tamoxifen—pancreatic cancer	0.0197	0.0262	CbGbCtD
Quinidine—CYP2B6—Tamoxifen—pancreatic cancer	0.0195	0.0259	CbGbCtD
Quinidine—ABCC2—Docetaxel—pancreatic cancer	0.0172	0.0229	CbGbCtD
Quinidine—ABCC2—Sunitinib—pancreatic cancer	0.0171	0.0228	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0157	0.0209	CbGbCtD
Quinidine—CYP3A7—Irinotecan—pancreatic cancer	0.0157	0.0209	CbGbCtD
Quinidine—CYP2B6—Irinotecan—pancreatic cancer	0.0149	0.0199	CbGbCtD
Quinidine—CYP2C8—Tamoxifen—pancreatic cancer	0.0147	0.0196	CbGbCtD
Quinidine—CYP1A2—Dacarbazine—pancreatic cancer	0.0143	0.0191	CbGbCtD
Quinidine—ABCB11—bile duct—pancreatic cancer	0.0138	0.22	CbGeAlD
Quinidine—ABCC2—Doxorubicin—pancreatic cancer	0.0128	0.0171	CbGbCtD
Quinidine—CYP2C8—Erlotinib—pancreatic cancer	0.0125	0.0167	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0115	0.0153	CbGbCtD
Quinidine—CYP3A7—Docetaxel—pancreatic cancer	0.0115	0.0153	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0115	0.0152	CbGbCtD
Quinidine—CYP3A7—Sunitinib—pancreatic cancer	0.0115	0.0152	CbGbCtD
Quinidine—CYP1A2—Tamoxifen—pancreatic cancer	0.0114	0.0152	CbGbCtD
Quinidine—CYP2C8—Fluorouracil—pancreatic cancer	0.0109	0.0144	CbGbCtD
Quinidine—ABCB11—bile—pancreatic cancer	0.0106	0.169	CbGeAlD
Quinidine—CYP2C9—Tamoxifen—pancreatic cancer	0.0103	0.0137	CbGbCtD
Quinidine—ABCB1—Tamoxifen—pancreatic cancer	0.00998	0.0133	CbGbCtD
Quinidine—CYP1A2—Erlotinib—pancreatic cancer	0.0097	0.0129	CbGbCtD
Quinidine—CYP2D6—Tamoxifen—pancreatic cancer	0.0094	0.0125	CbGbCtD
Quinidine—ABCB1—Gemcitabine—pancreatic cancer	0.0086	0.0114	CbGbCtD
Quinidine—ABCB1—Erlotinib—pancreatic cancer	0.00849	0.0113	CbGbCtD
Quinidine—CYP1A2—Fluorouracil—pancreatic cancer	0.00841	0.0112	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—pancreatic cancer	0.00817	0.0108	CbGbCtD
Quinidine—CYP2D6—Erlotinib—pancreatic cancer	0.008	0.0106	CbGbCtD
Quinidine—ABCB1—Irinotecan—pancreatic cancer	0.00766	0.0102	CbGbCtD
Quinidine—CYP2C9—Fluorouracil—pancreatic cancer	0.00758	0.0101	CbGbCtD
Quinidine—ABCC2—bile duct—pancreatic cancer	0.00703	0.112	CbGeAlD
Quinidine—ORM1—bile—pancreatic cancer	0.00658	0.105	CbGeAlD
Quinidine—CYP3A4—Tamoxifen—pancreatic cancer	0.00598	0.00794	CbGbCtD
Quinidine—ABCB1—Docetaxel—pancreatic cancer	0.00562	0.00746	CbGbCtD
Quinidine—ABCB1—Sunitinib—pancreatic cancer	0.00559	0.00743	CbGbCtD
Quinidine—ABCC2—bile—pancreatic cancer	0.0054	0.0861	CbGeAlD
Quinidine—CYP3A4—Erlotinib—pancreatic cancer	0.00508	0.00676	CbGbCtD
Quinidine—CYP3A4—Irinotecan—pancreatic cancer	0.00459	0.0061	CbGbCtD
Quinidine—ABCB1—Doxorubicin—pancreatic cancer	0.00419	0.00556	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—pancreatic cancer	0.00394	0.00524	CbGbCtD
Quinidine—KCNK6—pancreas—pancreatic cancer	0.00348	0.0555	CbGeAlD
Quinidine—CYP3A4—Docetaxel—pancreatic cancer	0.00336	0.00447	CbGbCtD
Quinidine—CYP3A4—Sunitinib—pancreatic cancer	0.00335	0.00445	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—pancreatic cancer	0.00251	0.00333	CbGbCtD
Quinidine—KCNK1—islet of Langerhans—pancreatic cancer	0.00219	0.035	CbGeAlD
Quinidine—ORM1—gall bladder—pancreatic cancer	0.00183	0.0291	CbGeAlD
Quinidine—KCNK1—pancreas—pancreatic cancer	0.00154	0.0246	CbGeAlD
Quinidine—ABCB11—digestive system—pancreatic cancer	0.00116	0.0185	CbGeAlD
Quinidine—SLC22A2—digestive system—pancreatic cancer	0.000931	0.0148	CbGeAlD
Quinidine—KCNH2—islet of Langerhans—pancreatic cancer	0.000806	0.0128	CbGeAlD
Quinidine—SCN5A—digestive system—pancreatic cancer	0.000787	0.0125	CbGeAlD
Quinidine—SLCO1B1—digestive system—pancreatic cancer	0.000778	0.0124	CbGeAlD
Quinidine—SLC22A4—digestive system—pancreatic cancer	0.000691	0.011	CbGeAlD
Quinidine—SLCO1A2—digestive system—pancreatic cancer	0.000634	0.0101	CbGeAlD
Quinidine—ABCC2—digestive system—pancreatic cancer	0.00059	0.00941	CbGeAlD
Quinidine—SLC22A5—digestive system—pancreatic cancer	0.000457	0.00729	CbGeAlD
Quinidine—CYP1A2—digestive system—pancreatic cancer	0.000414	0.0066	CbGeAlD
Quinidine—CYP1A1—digestive system—pancreatic cancer	0.000409	0.00651	CbGeAlD
Quinidine—CYP2B6—digestive system—pancreatic cancer	0.000397	0.00633	CbGeAlD
Quinidine—CYP2C9—digestive system—pancreatic cancer	0.000393	0.00627	CbGeAlD
Quinidine—CYP2E1—digestive system—pancreatic cancer	0.000373	0.00594	CbGeAlD
Quinidine—ABCB1—islet of Langerhans—pancreatic cancer	0.000354	0.00563	CbGeAlD
Quinidine—CYP3A4—digestive system—pancreatic cancer	0.0003	0.00478	CbGeAlD
Quinidine—CYP2D6—digestive system—pancreatic cancer	0.000295	0.0047	CbGeAlD
Quinidine—ABCB1—pancreas—pancreatic cancer	0.000249	0.00396	CbGeAlD
Quinidine—ABCB1—digestive system—pancreatic cancer	0.000212	0.00338	CbGeAlD
Quinidine—Rash—Erlotinib—pancreatic cancer	0.000176	0.0011	CcSEcCtD
Quinidine—Dermatitis—Erlotinib—pancreatic cancer	0.000176	0.0011	CcSEcCtD
Quinidine—Immune system disorder—Docetaxel—pancreatic cancer	0.000175	0.00109	CcSEcCtD
Quinidine—Headache—Erlotinib—pancreatic cancer	0.000175	0.00109	CcSEcCtD
Quinidine—Diplopia—Doxorubicin—pancreatic cancer	0.000175	0.00109	CcSEcCtD
Quinidine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000175	0.00109	CcSEcCtD
Quinidine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000175	0.00109	CcSEcCtD
Quinidine—Chills—Docetaxel—pancreatic cancer	0.000174	0.00109	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000174	0.00109	CcSEcCtD
Quinidine—Asthenia—Sunitinib—pancreatic cancer	0.000174	0.00108	CcSEcCtD
Quinidine—Decreased appetite—Irinotecan—pancreatic cancer	0.000173	0.00108	CcSEcCtD
Quinidine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000173	0.00108	CcSEcCtD
Quinidine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000173	0.00108	CcSEcCtD
Quinidine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000173	0.00108	CcSEcCtD
Quinidine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000172	0.00107	CcSEcCtD
Quinidine—Pruritus—Sunitinib—pancreatic cancer	0.000171	0.00107	CcSEcCtD
Quinidine—Breast disorder—Epirubicin—pancreatic cancer	0.000171	0.00107	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00017	0.00106	CcSEcCtD
Quinidine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00017	0.00106	CcSEcCtD
Quinidine—Mental disorder—Docetaxel—pancreatic cancer	0.00017	0.00106	CcSEcCtD
Quinidine—Erythema—Docetaxel—pancreatic cancer	0.000169	0.00105	CcSEcCtD
Quinidine—Malnutrition—Docetaxel—pancreatic cancer	0.000169	0.00105	CcSEcCtD
Quinidine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000169	0.00105	CcSEcCtD
Quinidine—Nausea—Tamoxifen—pancreatic cancer	0.000168	0.00105	CcSEcCtD
Quinidine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000168	0.00105	CcSEcCtD
Quinidine—Muscular weakness—Epirubicin—pancreatic cancer	0.000167	0.00104	CcSEcCtD
Quinidine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000166	0.00104	CcSEcCtD
Quinidine—Nausea—Erlotinib—pancreatic cancer	0.000166	0.00104	CcSEcCtD
Quinidine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000166	0.00104	CcSEcCtD
Quinidine—Diarrhoea—Sunitinib—pancreatic cancer	0.000166	0.00103	CcSEcCtD
Quinidine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000165	0.00103	CcSEcCtD
Quinidine—Ataxia—Doxorubicin—pancreatic cancer	0.000165	0.00103	CcSEcCtD
Quinidine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000164	0.00103	CcSEcCtD
Quinidine—Asthma—Epirubicin—pancreatic cancer	0.000164	0.00102	CcSEcCtD
Quinidine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000163	0.00102	CcSEcCtD
Quinidine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000162	0.00101	CcSEcCtD
Quinidine—Dizziness—Sunitinib—pancreatic cancer	0.00016	0.000999	CcSEcCtD
Quinidine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00016	0.000999	CcSEcCtD
Quinidine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00016	0.000998	CcSEcCtD
Quinidine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00016	0.000998	CcSEcCtD
Quinidine—Angina pectoris—Epirubicin—pancreatic cancer	0.000159	0.000994	CcSEcCtD
Quinidine—Breast disorder—Doxorubicin—pancreatic cancer	0.000158	0.000987	CcSEcCtD
Quinidine—Abdominal pain—Irinotecan—pancreatic cancer	0.000158	0.000984	CcSEcCtD
Quinidine—Body temperature increased—Irinotecan—pancreatic cancer	0.000158	0.000984	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000158	0.000984	CcSEcCtD
Quinidine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000157	0.000982	CcSEcCtD
Quinidine—Pancytopenia—Epirubicin—pancreatic cancer	0.000155	0.000969	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000154	0.000963	CcSEcCtD
Quinidine—Vomiting—Sunitinib—pancreatic cancer	0.000154	0.00096	CcSEcCtD
Quinidine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000154	0.000958	CcSEcCtD
Quinidine—Neutropenia—Epirubicin—pancreatic cancer	0.000153	0.000954	CcSEcCtD
Quinidine—Rash—Sunitinib—pancreatic cancer	0.000153	0.000952	CcSEcCtD
Quinidine—Dermatitis—Sunitinib—pancreatic cancer	0.000153	0.000952	CcSEcCtD
Quinidine—Urticaria—Fluorouracil—pancreatic cancer	0.000152	0.000947	CcSEcCtD
Quinidine—Headache—Sunitinib—pancreatic cancer	0.000152	0.000946	CcSEcCtD
Quinidine—Syncope—Docetaxel—pancreatic cancer	0.000151	0.000945	CcSEcCtD
Quinidine—Asthma—Doxorubicin—pancreatic cancer	0.000151	0.000944	CcSEcCtD
Quinidine—Leukopenia—Docetaxel—pancreatic cancer	0.000151	0.000943	CcSEcCtD
Quinidine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000151	0.000942	CcSEcCtD
Quinidine—Palpitations—Docetaxel—pancreatic cancer	0.000149	0.000931	CcSEcCtD
Quinidine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000149	0.000931	CcSEcCtD
Quinidine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000148	0.000926	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000147	0.00092	CcSEcCtD
Quinidine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000147	0.000917	CcSEcCtD
Quinidine—Convulsion—Docetaxel—pancreatic cancer	0.000146	0.000913	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000145	0.000902	CcSEcCtD
Quinidine—Chest pain—Docetaxel—pancreatic cancer	0.000144	0.000897	CcSEcCtD
Quinidine—Myalgia—Docetaxel—pancreatic cancer	0.000144	0.000897	CcSEcCtD
Quinidine—Nausea—Sunitinib—pancreatic cancer	0.000144	0.000897	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000144	0.000896	CcSEcCtD
Quinidine—Renal failure—Epirubicin—pancreatic cancer	0.000143	0.000894	CcSEcCtD
Quinidine—Asthenia—Irinotecan—pancreatic cancer	0.000143	0.000893	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000143	0.000891	CcSEcCtD
Quinidine—Jaundice—Epirubicin—pancreatic cancer	0.000142	0.000887	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—pancreatic cancer	0.000141	0.000883	CcSEcCtD
Quinidine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000141	0.000878	CcSEcCtD
Quinidine—Sweating—Epirubicin—pancreatic cancer	0.00014	0.000872	CcSEcCtD
Quinidine—Asthenia—Gemcitabine—pancreatic cancer	0.000139	0.00087	CcSEcCtD
Quinidine—Confusional state—Docetaxel—pancreatic cancer	0.000139	0.000867	CcSEcCtD
Quinidine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000138	0.000862	CcSEcCtD
Quinidine—Oedema—Docetaxel—pancreatic cancer	0.000138	0.00086	CcSEcCtD
Quinidine—Pruritus—Gemcitabine—pancreatic cancer	0.000137	0.000858	CcSEcCtD
Quinidine—Diarrhoea—Irinotecan—pancreatic cancer	0.000136	0.000851	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000136	0.000849	CcSEcCtD
Quinidine—Shock—Docetaxel—pancreatic cancer	0.000136	0.000846	CcSEcCtD
Quinidine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000135	0.000844	CcSEcCtD
Quinidine—Pruritus—Fluorouracil—pancreatic cancer	0.000135	0.000843	CcSEcCtD
Quinidine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000135	0.000842	CcSEcCtD
Quinidine—Tachycardia—Docetaxel—pancreatic cancer	0.000135	0.000839	CcSEcCtD
Quinidine—Skin disorder—Docetaxel—pancreatic cancer	0.000134	0.000835	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000134	0.000834	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—pancreatic cancer	0.000133	0.000831	CcSEcCtD
Quinidine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000133	0.000829	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—pancreatic cancer	0.000133	0.000827	CcSEcCtD
Quinidine—Dizziness—Irinotecan—pancreatic cancer	0.000132	0.000823	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—pancreatic cancer	0.000132	0.000821	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—pancreatic cancer	0.000131	0.00082	CcSEcCtD
Quinidine—Anorexia—Docetaxel—pancreatic cancer	0.000131	0.00082	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—pancreatic cancer	0.000131	0.000817	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—pancreatic cancer	0.000131	0.000817	CcSEcCtD
Quinidine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000131	0.000815	CcSEcCtD
Quinidine—Sweating—Doxorubicin—pancreatic cancer	0.000129	0.000807	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000129	0.000806	CcSEcCtD
Quinidine—Hypotension—Docetaxel—pancreatic cancer	0.000129	0.000804	CcSEcCtD
Quinidine—Urethral disorder—Epirubicin—pancreatic cancer	0.000128	0.0008	CcSEcCtD
Quinidine—Vomiting—Irinotecan—pancreatic cancer	0.000127	0.000791	CcSEcCtD
Quinidine—Dizziness—Fluorouracil—pancreatic cancer	0.000126	0.000788	CcSEcCtD
Quinidine—Visual impairment—Epirubicin—pancreatic cancer	0.000126	0.000787	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000126	0.000785	CcSEcCtD
Quinidine—Rash—Irinotecan—pancreatic cancer	0.000126	0.000785	CcSEcCtD
Quinidine—Dermatitis—Irinotecan—pancreatic cancer	0.000126	0.000784	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000126	0.000784	CcSEcCtD
Quinidine—Headache—Irinotecan—pancreatic cancer	0.000125	0.000779	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000124	0.000772	CcSEcCtD
Quinidine—Vomiting—Gemcitabine—pancreatic cancer	0.000124	0.000771	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—pancreatic cancer	0.000123	0.000769	CcSEcCtD
Quinidine—Dyspnoea—Docetaxel—pancreatic cancer	0.000123	0.000767	CcSEcCtD
Quinidine—Rash—Gemcitabine—pancreatic cancer	0.000122	0.000764	CcSEcCtD
Quinidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000122	0.000764	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—pancreatic cancer	0.000122	0.000763	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—pancreatic cancer	0.000122	0.000761	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000122	0.000759	CcSEcCtD
Quinidine—Headache—Gemcitabine—pancreatic cancer	0.000122	0.000759	CcSEcCtD
Quinidine—Flushing—Epirubicin—pancreatic cancer	0.000121	0.000758	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000121	0.000758	CcSEcCtD
Quinidine—Vomiting—Fluorouracil—pancreatic cancer	0.000121	0.000758	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000121	0.000756	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—pancreatic cancer	0.000121	0.000756	CcSEcCtD
Quinidine—Rash—Fluorouracil—pancreatic cancer	0.00012	0.000751	CcSEcCtD
Quinidine—Dermatitis—Fluorouracil—pancreatic cancer	0.00012	0.000751	CcSEcCtD
Quinidine—Decreased appetite—Docetaxel—pancreatic cancer	0.00012	0.000748	CcSEcCtD
Quinidine—Headache—Fluorouracil—pancreatic cancer	0.00012	0.000747	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00012	0.000746	CcSEcCtD
Quinidine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000119	0.000743	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000119	0.000741	CcSEcCtD
Quinidine—Nausea—Irinotecan—pancreatic cancer	0.000118	0.000739	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—pancreatic cancer	0.000118	0.000738	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000118	0.000736	CcSEcCtD
Quinidine—Chills—Epirubicin—pancreatic cancer	0.000117	0.000733	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—pancreatic cancer	0.000117	0.000728	CcSEcCtD
Quinidine—Nausea—Gemcitabine—pancreatic cancer	0.000115	0.00072	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—pancreatic cancer	0.000115	0.000715	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000115	0.000714	CcSEcCtD
Quinidine—Erythema—Epirubicin—pancreatic cancer	0.000114	0.000711	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—pancreatic cancer	0.000114	0.000711	CcSEcCtD
Quinidine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000114	0.000709	CcSEcCtD
Quinidine—Nausea—Fluorouracil—pancreatic cancer	0.000113	0.000708	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—pancreatic cancer	0.000113	0.000706	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—pancreatic cancer	0.000113	0.000704	CcSEcCtD
Quinidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000113	0.000703	CcSEcCtD
Quinidine—Flushing—Doxorubicin—pancreatic cancer	0.000112	0.000701	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000112	0.000701	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000109	0.000682	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000109	0.000681	CcSEcCtD
Quinidine—Body temperature increased—Docetaxel—pancreatic cancer	0.000109	0.00068	CcSEcCtD
Quinidine—Abdominal pain—Docetaxel—pancreatic cancer	0.000109	0.00068	CcSEcCtD
Quinidine—Chills—Doxorubicin—pancreatic cancer	0.000109	0.000678	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—pancreatic cancer	0.000107	0.00067	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—pancreatic cancer	0.000106	0.000662	CcSEcCtD
Quinidine—Erythema—Doxorubicin—pancreatic cancer	0.000105	0.000658	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—pancreatic cancer	0.000105	0.000658	CcSEcCtD
Quinidine—Agitation—Epirubicin—pancreatic cancer	0.000105	0.000653	CcSEcCtD
Quinidine—Vertigo—Epirubicin—pancreatic cancer	0.000102	0.000639	CcSEcCtD
Quinidine—Syncope—Epirubicin—pancreatic cancer	0.000102	0.000637	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—pancreatic cancer	0.000102	0.000636	CcSEcCtD
Quinidine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000102	0.000634	CcSEcCtD
Quinidine—Palpitations—Epirubicin—pancreatic cancer	0.000101	0.000628	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—pancreatic cancer	0.0001	0.000625	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—pancreatic cancer	9.94e-05	0.00062	CcSEcCtD
Quinidine—Asthenia—Docetaxel—pancreatic cancer	9.89e-05	0.000617	CcSEcCtD
Quinidine—Convulsion—Epirubicin—pancreatic cancer	9.87e-05	0.000616	CcSEcCtD
Quinidine—Pruritus—Docetaxel—pancreatic cancer	9.75e-05	0.000609	CcSEcCtD
Quinidine—Myalgia—Epirubicin—pancreatic cancer	9.7e-05	0.000605	CcSEcCtD
Quinidine—Chest pain—Epirubicin—pancreatic cancer	9.7e-05	0.000605	CcSEcCtD
Quinidine—Agitation—Doxorubicin—pancreatic cancer	9.69e-05	0.000604	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.63e-05	0.000601	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—pancreatic cancer	9.47e-05	0.000591	CcSEcCtD
Quinidine—Syncope—Doxorubicin—pancreatic cancer	9.45e-05	0.00059	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—pancreatic cancer	9.44e-05	0.000589	CcSEcCtD
Quinidine—Diarrhoea—Docetaxel—pancreatic cancer	9.43e-05	0.000589	CcSEcCtD
Quinidine—Confusional state—Epirubicin—pancreatic cancer	9.38e-05	0.000585	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—pancreatic cancer	9.32e-05	0.000581	CcSEcCtD
Quinidine—Oedema—Epirubicin—pancreatic cancer	9.3e-05	0.00058	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—pancreatic cancer	9.27e-05	0.000578	CcSEcCtD
Quinidine—Shock—Epirubicin—pancreatic cancer	9.15e-05	0.000571	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—pancreatic cancer	9.13e-05	0.00057	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—pancreatic cancer	9.12e-05	0.000569	CcSEcCtD
Quinidine—Dizziness—Docetaxel—pancreatic cancer	9.12e-05	0.000569	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—pancreatic cancer	9.1e-05	0.000568	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—pancreatic cancer	9.08e-05	0.000566	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—pancreatic cancer	9.03e-05	0.000564	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—pancreatic cancer	8.99e-05	0.000561	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—pancreatic cancer	8.97e-05	0.00056	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—pancreatic cancer	8.97e-05	0.00056	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.91e-05	0.000556	CcSEcCtD
Quinidine—Anorexia—Epirubicin—pancreatic cancer	8.86e-05	0.000553	CcSEcCtD
Quinidine—Vomiting—Docetaxel—pancreatic cancer	8.77e-05	0.000547	CcSEcCtD
Quinidine—Rash—Docetaxel—pancreatic cancer	8.69e-05	0.000542	CcSEcCtD
Quinidine—Hypotension—Epirubicin—pancreatic cancer	8.69e-05	0.000542	CcSEcCtD
Quinidine—Dermatitis—Docetaxel—pancreatic cancer	8.68e-05	0.000542	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—pancreatic cancer	8.68e-05	0.000541	CcSEcCtD
Quinidine—Headache—Docetaxel—pancreatic cancer	8.64e-05	0.000539	CcSEcCtD
Quinidine—Oedema—Doxorubicin—pancreatic cancer	8.6e-05	0.000537	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.47e-05	0.000529	CcSEcCtD
Quinidine—Shock—Doxorubicin—pancreatic cancer	8.46e-05	0.000528	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—pancreatic cancer	8.44e-05	0.000526	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.42e-05	0.000526	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—pancreatic cancer	8.4e-05	0.000524	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—pancreatic cancer	8.36e-05	0.000521	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.32e-05	0.000519	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—pancreatic cancer	8.29e-05	0.000517	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—pancreatic cancer	8.2e-05	0.000512	CcSEcCtD
Quinidine—Nausea—Docetaxel—pancreatic cancer	8.19e-05	0.000511	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—pancreatic cancer	8.08e-05	0.000504	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—pancreatic cancer	8.04e-05	0.000502	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.03e-05	0.000501	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.84e-05	0.000489	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—pancreatic cancer	7.67e-05	0.000479	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—pancreatic cancer	7.66e-05	0.000478	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.6e-05	0.000474	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—pancreatic cancer	7.48e-05	0.000467	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.43e-05	0.000463	CcSEcCtD
Quinidine—Urticaria—Epirubicin—pancreatic cancer	7.39e-05	0.000461	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—pancreatic cancer	7.35e-05	0.000459	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—pancreatic cancer	7.35e-05	0.000459	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—pancreatic cancer	7.09e-05	0.000442	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.04e-05	0.000439	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—pancreatic cancer	6.85e-05	0.000427	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—pancreatic cancer	6.83e-05	0.000426	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—pancreatic cancer	6.8e-05	0.000424	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—pancreatic cancer	6.8e-05	0.000424	CcSEcCtD
Quinidine—Asthenia—Epirubicin—pancreatic cancer	6.67e-05	0.000416	CcSEcCtD
Quinidine—Pruritus—Epirubicin—pancreatic cancer	6.58e-05	0.00041	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—pancreatic cancer	6.36e-05	0.000397	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—pancreatic cancer	6.34e-05	0.000395	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—pancreatic cancer	6.17e-05	0.000385	CcSEcCtD
Quinidine—Dizziness—Epirubicin—pancreatic cancer	6.15e-05	0.000384	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—pancreatic cancer	6.09e-05	0.00038	CcSEcCtD
Quinidine—Vomiting—Epirubicin—pancreatic cancer	5.91e-05	0.000369	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—pancreatic cancer	5.89e-05	0.000367	CcSEcCtD
Quinidine—Rash—Epirubicin—pancreatic cancer	5.86e-05	0.000366	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—pancreatic cancer	5.86e-05	0.000365	CcSEcCtD
Quinidine—Headache—Epirubicin—pancreatic cancer	5.83e-05	0.000363	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—pancreatic cancer	5.69e-05	0.000355	CcSEcCtD
Quinidine—Nausea—Epirubicin—pancreatic cancer	5.52e-05	0.000345	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—pancreatic cancer	5.47e-05	0.000341	CcSEcCtD
Quinidine—Rash—Doxorubicin—pancreatic cancer	5.42e-05	0.000338	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—pancreatic cancer	5.42e-05	0.000338	CcSEcCtD
Quinidine—Headache—Doxorubicin—pancreatic cancer	5.39e-05	0.000336	CcSEcCtD
Quinidine—Nausea—Doxorubicin—pancreatic cancer	5.11e-05	0.000319	CcSEcCtD
Quinidine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	5.38e-06	0.000221	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.37e-06	0.000221	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PPARG—pancreatic cancer	5.35e-06	0.00022	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.34e-06	0.00022	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—GCG—pancreatic cancer	5.3e-06	0.000218	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—DPYD—pancreatic cancer	5.3e-06	0.000218	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—APOE—pancreatic cancer	5.25e-06	0.000216	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	5.24e-06	0.000215	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CD44—pancreatic cancer	5.22e-06	0.000214	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	5.21e-06	0.000214	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.11e-06	0.00021	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—STK11—pancreatic cancer	5.09e-06	0.000209	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CB—pancreatic cancer	5.08e-06	0.000209	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.07e-06	0.000208	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	5.07e-06	0.000208	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.06e-06	0.000208	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.04e-06	0.000207	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTGS2—pancreatic cancer	5.04e-06	0.000207	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	5.03e-06	0.000207	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—GCG—pancreatic cancer	5e-06	0.000206	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—STK11—pancreatic cancer	4.99e-06	0.000205	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.97e-06	0.000204	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	4.97e-06	0.000204	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.97e-06	0.000204	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	4.9e-06	0.000201	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	4.87e-06	0.0002	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.87e-06	0.0002	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—APOE—pancreatic cancer	4.82e-06	0.000198	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—APOE—pancreatic cancer	4.81e-06	0.000198	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.8e-06	0.000197	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CD44—pancreatic cancer	4.78e-06	0.000197	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	4.74e-06	0.000195	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.71e-06	0.000194	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—STK11—pancreatic cancer	4.7e-06	0.000193	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.68e-06	0.000192	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.64e-06	0.000191	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.61e-06	0.000189	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.6e-06	0.000189	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GCG—pancreatic cancer	4.59e-06	0.000188	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	4.57e-06	0.000188	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.53e-06	0.000186	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—APOE—pancreatic cancer	4.48e-06	0.000184	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.42e-06	0.000182	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.41e-06	0.000181	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.4e-06	0.000181	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTEN—pancreatic cancer	4.39e-06	0.000181	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—TYMS—pancreatic cancer	4.38e-06	0.00018	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.37e-06	0.00018	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	4.35e-06	0.000179	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	4.34e-06	0.000178	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—STK11—pancreatic cancer	4.31e-06	0.000177	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.29e-06	0.000177	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	4.29e-06	0.000176	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—TYMS—pancreatic cancer	4.29e-06	0.000176	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.25e-06	0.000175	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.25e-06	0.000175	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	4.24e-06	0.000174	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	4.21e-06	0.000173	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PPARG—pancreatic cancer	4.2e-06	0.000172	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	4.19e-06	0.000172	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PPARG—pancreatic cancer	4.19e-06	0.000172	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CD44—pancreatic cancer	4.17e-06	0.000171	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	4.16e-06	0.000171	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.1e-06	0.000169	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.05e-06	0.000166	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	4.05e-06	0.000166	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—TYMS—pancreatic cancer	4.04e-06	0.000166	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	4.01e-06	0.000165	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GCG—pancreatic cancer	3.99e-06	0.000164	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CD44—pancreatic cancer	3.93e-06	0.000161	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—pancreatic cancer	3.9e-06	0.00016	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CD44—pancreatic cancer	3.89e-06	0.00016	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	3.86e-06	0.000159	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	3.82e-06	0.000157	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	3.82e-06	0.000157	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.81e-06	0.000157	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.78e-06	0.000155	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GCG—pancreatic cancer	3.76e-06	0.000155	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—STK11—pancreatic cancer	3.76e-06	0.000154	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.74e-06	0.000154	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GCG—pancreatic cancer	3.73e-06	0.000153	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.71e-06	0.000152	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	3.67e-06	0.000151	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—pancreatic cancer	3.67e-06	0.000151	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	3.63e-06	0.000149	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	3.6e-06	0.000148	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—APOE—pancreatic cancer	3.56e-06	0.000146	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	3.56e-06	0.000146	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.55e-06	0.000146	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—STK11—pancreatic cancer	3.54e-06	0.000145	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	3.51e-06	0.000144	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—STK11—pancreatic cancer	3.51e-06	0.000144	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	3.5e-06	0.000144	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.49e-06	0.000144	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—APOE—pancreatic cancer	3.49e-06	0.000143	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	3.43e-06	0.000141	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	3.36e-06	0.000138	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	3.33e-06	0.000137	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CD44—pancreatic cancer	3.33e-06	0.000137	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	3.33e-06	0.000137	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.31e-06	0.000136	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—pancreatic cancer	3.3e-06	0.000136	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	3.3e-06	0.000135	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.29e-06	0.000135	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—APOE—pancreatic cancer	3.29e-06	0.000135	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.26e-06	0.000134	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TYMS—pancreatic cancer	3.23e-06	0.000133	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.23e-06	0.000133	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	3.21e-06	0.000132	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	3.2e-06	0.000131	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GCG—pancreatic cancer	3.19e-06	0.000131	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	3.16e-06	0.00013	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	3.15e-06	0.000129	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	3.14e-06	0.000129	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.11e-06	0.000128	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—pancreatic cancer	3.1e-06	0.000128	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	3.1e-06	0.000127	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CA—pancreatic cancer	3.1e-06	0.000127	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	3.09e-06	0.000127	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	3.09e-06	0.000127	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	3.07e-06	0.000126	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	3.06e-06	0.000126	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.04e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—pancreatic cancer	3.04e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.02e-06	0.000124	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—APOE—pancreatic cancer	3.02e-06	0.000124	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—STK11—pancreatic cancer	3e-06	0.000123	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	2.97e-06	0.000122	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—pancreatic cancer	2.88e-06	0.000118	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—pancreatic cancer	2.87e-06	0.000118	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—pancreatic cancer	2.87e-06	0.000118	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.85e-06	0.000117	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	2.83e-06	0.000116	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	2.82e-06	0.000116	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.81e-06	0.000116	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	2.77e-06	0.000114	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.72e-06	0.000112	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	2.72e-06	0.000112	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.69e-06	0.000111	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—pancreatic cancer	2.68e-06	0.00011	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	2.66e-06	0.000109	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—APOE—pancreatic cancer	2.63e-06	0.000108	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.63e-06	0.000108	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	2.61e-06	0.000107	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	2.59e-06	0.000106	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.58e-06	0.000106	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CD44—pancreatic cancer	2.57e-06	0.000105	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—pancreatic cancer	2.53e-06	0.000104	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—APOE—pancreatic cancer	2.48e-06	0.000102	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	2.46e-06	0.000101	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GCG—pancreatic cancer	2.46e-06	0.000101	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—APOE—pancreatic cancer	2.45e-06	0.000101	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.45e-06	0.000101	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	2.44e-06	0.0001	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	2.41e-06	9.92e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.39e-06	9.83e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	2.39e-06	9.83e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.37e-06	9.75e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	2.37e-06	9.74e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.32e-06	9.55e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—STK11—pancreatic cancer	2.31e-06	9.51e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—pancreatic cancer	2.29e-06	9.41e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	2.28e-06	9.36e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	2.27e-06	9.35e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	2.26e-06	9.3e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—pancreatic cancer	2.25e-06	9.26e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.23e-06	9.18e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.22e-06	9.1e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	2.21e-06	9.09e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.2e-06	9.05e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.18e-06	8.96e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.16e-06	8.86e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.14e-06	8.79e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—pancreatic cancer	2.13e-06	8.75e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.12e-06	8.72e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—pancreatic cancer	2.11e-06	8.69e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.1e-06	8.64e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—APOE—pancreatic cancer	2.1e-06	8.62e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	8.57e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—pancreatic cancer	2.08e-06	8.57e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.08e-06	8.57e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.07e-06	8.49e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.06e-06	8.47e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.05e-06	8.42e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	8.35e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	2.03e-06	8.33e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2e-06	8.22e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.99e-06	8.18e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.99e-06	8.16e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—pancreatic cancer	1.97e-06	8.08e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.96e-06	8.07e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.95e-06	8e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.9e-06	7.81e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.89e-06	7.78e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	7.77e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.85e-06	7.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.83e-06	7.53e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.83e-06	7.51e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.83e-06	7.51e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.82e-06	7.47e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	1.81e-06	7.43e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.8e-06	7.41e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.8e-06	7.4e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.71e-06	7.04e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.7e-06	7e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.7e-06	6.98e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.7e-06	6.98e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.7e-06	6.97e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.68e-06	6.91e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.67e-06	6.84e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.66e-06	6.84e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—pancreatic cancer	1.66e-06	6.82e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—pancreatic cancer	1.66e-06	6.81e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.62e-06	6.65e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.57e-06	6.47e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.57e-06	6.45e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—pancreatic cancer	1.54e-06	6.34e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.5e-06	6.17e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.48e-06	6.08e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.47e-06	6.04e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.47e-06	6.03e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.46e-06	6e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.45e-06	5.96e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.45e-06	5.94e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.44e-06	5.91e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.41e-06	5.79e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.4e-06	5.75e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.39e-06	5.7e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.34e-06	5.5e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.28e-06	5.28e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	5.23e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.25e-06	5.15e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.23e-06	5.04e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.2e-06	4.94e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.18e-06	4.85e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.13e-06	4.66e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.12e-06	4.6e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.11e-06	4.56e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.11e-06	4.55e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.04e-06	4.29e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.04e-06	4.27e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.03e-06	4.25e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—pancreatic cancer	9.67e-07	3.98e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—pancreatic cancer	9.05e-07	3.72e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	8.84e-07	3.63e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—pancreatic cancer	8.53e-07	3.5e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—pancreatic cancer	8.45e-07	3.47e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—pancreatic cancer	7.22e-07	2.97e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.82e-07	2.8e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.57e-07	2.29e-05	CbGpPWpGaD
